Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $16.1600 (-2.71%) ($16.0650 - $16.1600) on Fri. Aug. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.86% (three month average) | RSI | 45 | Latest Price | $16.1600(-2.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.9% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) ARKK(37%) IWO(37%) SKYY(36%) | Factors Impacting BCRX price | BCRX will decline at least -1.93% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-7%) TBT(-3%) IGOV(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.93% (StdDev 3.86%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $16.58 | 5 Day Moving Average | $16.24(-0.49%) | 10 Day Moving Average | $16.55(-2.36%) | 20 Day Moving Average | $16.58(-2.53%) | To recent high | -8.6% | To recent low | 35.2% | Market Cap | $2.851b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |